News & Updates

Combination treatment with cagrilintide and semaglutide significantly reduced body weight in patients with overweight or obesity and type 2 diabetes (T2D), according to the REDEFINE 2 trial presented at EASD 2025.

Ovarian hormone suppression gets rid of symptom cyclicity in women with premenstrual dysphoric disorder (PMDD), reports a study. In addition, ovarian steroid addback results in the emergence of symptoms in those with PMDD but not in healthy comparison women.

Women with gestational diabetes are at heightened risks of overall and specific cardiovascular diseases (CVDs), including chronic hypertension, according to a nationwide population‐based cohort study.

Semaglutide is as good as tirzepatide in the treatment of patients with cardiometabolic heart failure with preserved ejection fraction (HFpEF), with both drugs yielding substantial reduction in the risks of cardiac hospitalization and mortality compared with sitagliptin, as reported in a study.

Eating mangoes daily may help with glycaemic control, insulin sensitivity, and body composition in adults with prediabetes, as shown in a study.

Patients with post-transplantation diabetes mellitus (PTDM) tend to be older and have higher BMI, triglyceride levels, and hypertension, according to a study.